-
Federal Suit Seeking Names of Some Jewish Employees at Penn Sparks Backlash
The Trump administration says it needs the information to investigate antisemitism and accuses the university of flouting a subpoena.
-
How Olivia Nuzzi and Ryan Lizza Became Main Characters on Social Media
Love, politics and ethics collided as Olivia Nuzzi and Ryan Lizza went at it in a media sphere that rewards private revelations.
-
Why We Fall in Love: The Science Behind Romantic Attraction
Why We Fall in Love: The Science Behind Romantic Attraction There’s a moment when you catch someone’s eye and feel a flutter in your chest. It’s like a silent conversation where a glance speaks volumes. You might wonder, why do we fall in love? What is it about another person that draws us in, often…
-
The Rising Threats of Multi-Modal and Agentic AI in Cyber Attacks
The digital transformation has led to significant advancements in authentication and identity verification technologies and other cyber defenses. From biometrics to multi-factor authentication (MFA) to use of Artificial Intelligence (AI) enhanced detection and response tools, these systems are the first line of critical defense against unauthorized access in critical sectors such as finance, healthcare, manufacturing…
-
Hogan Lovells Living Mobility Spotlight Q&A Series
What is Living Mobility? It is easier to say what it is not. The automotive and mobility industry is no longer focused on the traditional vehicle. Not only are the vehicles changing but we are now focused on mobility: different modes of travel for people and goods all connected in new and evolving ways. As…
-
Behind the Scenes of Chemical Safety Reform — A Conversation with Ryan Schmit
This week I had the pleasure of speaking with Ryan N. Schmit, Of Counsel with B&C, and Senior Regulatory Consultant with The Acta Group (Acta®). Ryan joined us a few weeks ago and we wanted to show off our newest Toxic Substances Control Act (TSCA) superstar. We discuss Ryan’s illustrious career with the U.S. Environmental…
-
Federal Circuit Patent Watch: Petitioner Has No Right to Appeal “Deinstitution” of IPRs
In Re MOTOROLA SOLUTIONS, INC. [ORDER] (2025-134, 11/06/2025) (Dyk, Linn, Cunningham) Linn, J. The Court denied Motorola Solutions, Inc.’s petition for a writ of mandamus challenging the Acting Director’s decision to deinstitute several IPRs of Stellar, LLC’s patents….By: WilmerHale
-
FDA Approves Accord BioPharma’s Denosumab Biosimilars
On November 20, 2025, the FDA approved Accord BioPharma’s denosumab biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu), which reference Amgen’s PROLIA® and XGEVA®, respectively. This marks the eighth set of denosumab biosimilars approved by the FDA….By: Goodwin
-
Purdue Pharma’s $7.4 Billion Chapter 11 Plan Formally Approved
A federal bankruptcy court on November 18 formally approved Purdue’s $7.4 billion Chapter 11 plan to settle thousands of opioid-related lawsuits. The plan requires (1) a $6.5 billion contribution from the Sackler family members who own Purdue and (2) a $900 million contribution from Purdue itself….By: Knobbe Martens
-
European Leaders Back Zelensky After Trump’s Russia-Ukraine Peace Plan Excludes Them
A U.S.-Russian proposal would require Kyiv to give up territory and reduce its army. If Moscow complies with the terms, it could receive benefits including reintegration into the global economy.
